ATLASATLAS fair value
CA$5.36
Close to fair value · 7% discount
Range: CA$4.83–CA$5.90Fair valuePrice
Medexus Pharmaceuticals (MDP.TO)
Medexus Pharmaceuticals stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Toronto Stock Exchange · Canada
CA$4.97▲ +2.05%
Prices as of Oct 27, 2026 · CAD
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Medexus Pharmaceuticals in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Medexus Pharmaceuticals
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Medexus Pharmaceuticals's fair value at about CA$5.36 per share (reasonable range: CA$4.83 to CA$5.90). At CA$4.97, the stock trades within 8% of that figure: close to fair value.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Medexus Pharmaceuticals a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CA$4.64 and CA$5.32; in 9 out of 10, between CA$4.11 and CA$6.00. Estimated annual volatility is 29%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CA$150M
- Market cap (USD)
- $107M
- 52-week high
- CA$5.50
- 52-week low
- CA$2.51
- Revenue (12 months)
- $103M
- Gross margin
- 63.9%
- Operating margin
- 7.4%
- Net margin
- -2.3%
- Beta
- 1.73
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Medexus Pharmaceuticals sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks MDP.TO has traded between CA$2.51 and CA$5.50. Today it is 9.6% below that high and 98% above its low.
Its beta is 1.73: it tends to move more than the market, both up and down.
About the company
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases.
Want to see everything about Medexus Pharmaceuticals?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Medexus Pharmaceuticals (MDP.TO) fair value?
About CA$5.36 per share according to ATLAS (reasonable range: CA$4.83 to CA$5.90). With the stock at CA$4.97, it is close to that value.
What is the chance MDP.TO goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, MDP.TO ends the month between CA$4.64 and CA$5.32.
How big is Medexus Pharmaceuticals and what is its P/E ratio?
Medexus Pharmaceuticals's market capitalization is CA$150M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is MDP.TO?
ATLAS estimates annual volatility at 29%. In a typical month, half of the outcomes end between CA$4.64 and CA$5.32.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer